Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yosef Landman

Showing results (11-20 of 12) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 12 results.
Oncology|July 11, 2021
The Relationship of Diabetes Mellitus to Efficacy of Immune Checkpoint Inhibitors in Patients with Advanced Non-Small Cell Lung CancerOded Jacobi, Yosef Landman, Daniel Reinhorn, et al.
Journal of Thrombosis and Haemostasis : JTH|February 19, 2021
Venous thromboembolism incidence and risk assessment in lung cancer patients treated with immune checkpoint inhibitorsOded Icht, Naama Darzi, Shai Shimony, et al.
Pageof 2

Showing results (11-20 of 12) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 12 results.
Oncology|July 11, 2021
The Relationship of Diabetes Mellitus to Efficacy of Immune Checkpoint Inhibitors in Patients with Advanced Non-Small Cell Lung CancerOded Jacobi, Yosef Landman, Daniel Reinhorn, et al.
Journal of Thrombosis and Haemostasis : JTH|February 19, 2021
Venous thromboembolism incidence and risk assessment in lung cancer patients treated with immune checkpoint inhibitorsOded Icht, Naama Darzi, Shai Shimony, et al.
Pageof 2